Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. 2009 Profile Template Sketch
  2. 2012 Call Summaries
  3. 2013 Call Summaries
  4. 2014 Call Summaries
  5. 2015 Call Summaries
  6. 2016 Call Summaries
  7. 2019
  8. 2020
  9. 2021
  10. 2022-01-18 Process Committee Agenda
  11. 2022-02-01 Process Committee Agenda
  12. 2022-02-15 Process Committee Agenda
  13. 2022-03-01 Process Committee Agenda
  14. 2022-03-15 Process Committee Agenda
  15. 2022-04-05 Process Committee Agenda
  16. 2022-05-03 Process Committee Agenda
  17. 2022-05-17 Process Committee Agenda
  18. 2022-06-21 Process Committee Agenda
  19. 2022-07-05 Process Committee Agenda
  20. 2022-07-19 Process Committee Agenda
  21. 2022-08-02 Process Committee Agenda
  22. 2022-08-16 Process Committee Agenda
  23. 2022-09-06 Process Committee Agenda
  24. AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Ctte
  25. AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte
  26. ARCHIVE
  27. ASFNR Materials - Abstract for Review
  28. ASL Meeting Summaries Archive
  29. About QIBA
  30. Acquisition Protocols Technical Subcommittee
  31. Additional letters of support can be found here
  32. Agenda from 02.17.2012 FDG-PET Tech Committee Call
  33. Alzheimer's Disease PET Archive
  34. Ambition Levels for Collaboration
  35. Archive
  36. Archive - Initial Target Selection and Roadmap
  37. Archive - Lung Density
  38. Archive for Lung Nodule Assessment in CT Screening Draft Profiles
  39. Archive for previously known QIBA Modality Committees
  40. Archived: 2009 COPD/Asthma Call Summaries
  41. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries
  42. Archived: 2010 COPD/Asthma Call Summaries
  43. Archived: 2011 COPD/Asthma Call Summaries
  44. Archived: 2011 CT Volumetry - Group 3A Call Summaries
  45. Archived: 2012 CT Volumetry - Group 3A Call Summaries
  46. Archived: 2012 QIBA US SWS Technical Committee call summaries
  47. Archived: 2012 fMRI Reproducibility Call Summaries
  48. Archived: 2013 fMRI Bias WG Call Summaries
  49. Archived: 2014 fMRI Bias WG Call Summaries
  50. Archived: 2016 Lung Density BC Call Summaries
  51. Archived: fMRI Bias WG Call Summaries
  52. Archived: fMRI Reproducibility Call Summaries
  53. Archived "What is a Profile?" description as of 08.19.2011
  54. Archived - 2010-2011 fMRI Reproducibility Call Summaries
  55. Archived - 2011 fMRI Reproducibility Call Summaries
  56. Archived DCE-MRI Profiles
  57. Archived Versions
  58. Archived Versions of QIBA Vol CT - Group 3A draft documents
  59. Assessment Procedure Guidance
  60. Atherosclerosis Biomarkers Profile Draft Archive
  61. Balloting Process
  62. Bobby test
  63. CEUS BC Call Summaries
  64. CEUS Task Force (TF) Call Summaries
  65. COPD Group Call Summaries
  66. CTV-AD Considerations for Future Editions
  67. CT Acquisition Protocol Groundwork
  68. CT Angiography Biomarker Ctte
  69. CT Angiography Call Summaries Archive
  70. CT Angiography Profile Draft Archive
  71. CT Coordinating Committee
  72. CT Draft Proffered Protocols
  73. CT Small Lung Nodule Biomarker Ctte
  74. CT Volumetry BC Call Summaries Archive
  75. CT Volumetry Biomarker Ctte
  76. Call Agenda Topics
  77. Call Summaries
  78. Call Summaries Archive
  79. Catalog
  80. Change Tracking and File Naming
  81. Claim Confirmation Process
  82. Claim Guidance
  83. Claim Language/Detail
  84. Clinical Applications and Biological Targets Subcommittee
  85. Clinical Sites
  86. Clinical Trial Planning
  87. Clinical Trials Collaboration
  88. Columbia University Medical Center
  89. Combined: System Dependencies & Phantom Development Subcommittees
  90. Combined Nuclear Medicine Biomarker Committee Call Summaries
  91. Comment Resolutions
  92. Committee Organization
  93. Committee Procedures
  94. Committee Sunset Process
  95. Committee Template
  96. Committee on Image Archives
  97. Committee on Open Image Archives
  98. Committees
  99. Communications Committee
  100. Conformity Assessment
  101. Consensus Process
  102. Consensus Protocols
  103. CoreLab Partners, Inc.
  104. CoreLab Partners, Inc., Round-2
  105. Covariates Rationale
  106. DCE-MRI BC Call Summaries Archive
  107. DCE-MRI Project Page
  108. DCE MRI Biomarker Ctte
  109. DSC-MRI Call Summaries Archive
  110. DSC MRI Biomarker Ctte
  111. DTI MRI Biomarker Ctte
  112. DWI Literature Review
  113. DWI MR BC Call Summaries Archive
  114. DWI MR Biomarker Ctte
  115. DWI Profile Development Archive
  116. DWI Profile Draft Archive
  117. Dana-Farber Cancer Institute
  118. David Geffen School of Medicine at UCLA, Department of Radiology
  119. David Geffen School of Medicine at UCLA, Department of Radiology,Round-2
  120. Dept of Research Scatch Page
  121. Digital Reference Objects-Images
  122. Document Archive
  123. Documents / Call Summaries
  124. Dr Tucker's New Test Page
  125. Draft Consensus Protocols
  126. Draft New Main Page
  127. Draft Proffered Protocols
  128. Duke Brain Imaging and Analysis Center
  129. Duke University
  130. Duke University Medical Center
  131. EIBIR/QIBA ASL Biomarker Ctte
  132. Education
  133. Example Use Case for Open Image Archives
  134. Example Use Case for Open Image archives
  135. Executive Committee
  136. Executive Committee Call Summaries Archive
  137. Expressing Requirements
  138. FDG-PET/CT UPICT Template - (Editable)
  139. FDG-PET Archive
  140. FDG-PET Biomarker Ctte
  141. FDG-PET CT Template
  142. FDG-PET Call Summaries Archive
  143. FDG-PET Reference Material
  144. FMRI
  145. FMRI-DICOM WG Call Summaries
  146. FMRI Biomarker Ctte
  147. FMRI Call Summaries
  148. FMRI Call Summaries Archive
  149. FMRI Project Page
  150. FMRI Working Documents Archive
  151. FMRI moc profile
  152. Fmri PubMed search
  153. Follow-up Editorial
  154. Fused Images
  155. Ground Truth Strategy
  156. Groundwork and Profiling
  157. Group 3A Call Summaries Archive
  158. Guidance Document Process
  159. How To's
  160. How to Create a Google Doc
  161. How to Upload Documents to the UPICT Library
  162. How to Write a Profile
  163. How to use QIBA Profiles
  164. I-123 Biomarker Committee
  165. ISMRM/QIBA PDFF Biomarker Ctte
  166. Industry
  167. Initial Target Selection
  168. Invitation to Participate
  169. Joe's test
  170. Johns Hopkins Univ School of Medicine
  171. Johns Hopkins University School of Medicine
  172. Johns Hopkins University School of Medicine, Round-2
  173. Julie's COPD archive
  174. Julie's test
  175. Julie's test page
  176. Lesion Sizing Toolkit
  177. List of Certified Conformant Users (QIBA Tested)
  178. List of Registered Conformant Users (Self-attestation
  179. List of Registered Conformant Users (Self-attestation)
  180. Lung Density/COPD BC Call Summaries Archive
  181. Lung Density BC Call Summaries
  182. Lung Density Biomarker Ctte
  183. Lung Nodule Assessment in CT Screening Call Summary Archive
  184. MRE BC Call Summaries Archive
  185. MRE Biomarker Committee Call Summaries
  186. MRE Biomarker Ctte
  187. MR Acquisition Protocols
  188. MR Archive
  189. MR Coordinating Committee
  190. MR Draft Proffered Protocols
  191. MSK Biomarker Committee Call Summaries
  192. MSK Biomarker Committee Call Summaries Archive
  193. MSK Biomarker Ctte
  194. Main Page
  195. Maintenance Process
  196. Medical College of Wisconsin
  197. Metrology Committee
  198. Metrology Committee Call Summaries Archive
  199. Moc-up page
  200. Moc technical committee
  201. Modality Committee Archive
  202. Monthly FDG-PET Call Summaries
  203. Myocardial Blood Flow Biomarker Committee
  204. NIST
  205. NM Coordinating Committee
  206. New Protocol Here
  207. Normalization Process
  208. Orphan Documents
  209. PDFF Biomarker Committee Call Summaries
  210. PDFF Biomarker Committee Call Summaries Archive
  211. PDFF Biomarker Ctte
  212. PDF BC Call Summaries Archive
  213. PET Amyloid BC Call Summaries Archive
  214. PET Amyloid Biomarker Ctte
  215. PET Myocardial Blood Flow Biomarker Committee
  216. PET Myocardial Blood Flow Call Summaries
  217. PET Myocardial Blood Flow Call Summaries Archive
  218. PET Tau Biomarker Committee
  219. PUBLIC COMMENT WORK PAGE
  220. Perfusion, Diffusion and Flow-MRI Biomarker Ctte
  221. Perlman Advisory Group
  222. Phantom Development
  223. Phantom Development Subcommittee
  224. Phantom Development Technical Subcommittee
  225. Phantom Protocol & Data Analysis
  226. Phantoms And Tests Subcommittee
  227. Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)
  228. Pilot Conformance Projects Under Development
  229. Process
  230. Process Committee Agenda Archive
  231. Process Committee Call Summaries
  232. Process Committee Call Summaries Archive
  233. Process Coordinating Committee
  234. Process Education
  235. Proffered Protocols
  236. Profile: CT Lung Nodule - Small Nodule in Neoadjuvant Setting
  237. Profile: CT Lung Nodule - Small Nodule in neoadjuvant Setting
  238. Profile: CT Lung Nodule Response
  239. Profile: CT Lung Nodule Volume Change for Primary, Hilar and Medistinal Lymph Nodes
  240. Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites
  241. Profile: FDG-PET Whole Body
  242. Profile Conformance
  243. Profile Development
  244. Profile Editions
  245. Profile Strategy for Vol CT
  246. Profile drafts
  247. Profiles
  248. Project (19a): Validation of Breath Hold Task for Assessment of Cerebrovascular Responsiveness and Calibration of Language Activation Maps to Optimize Reproducibility
  249. Project 1a: Inter-scanner/ Inter-clinic Comparison of Reader Nodule Sizing in CT Imaging of a Phantom
  250. Project 2a: Assessing Measurement Variability of Lung Lesions in Patient Data Sets

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://qibawiki.rsna.org/index.php/Special:WithoutInterwiki"